Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Corbus Pharmaceuticals Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $25.0K in total
- Open-market sells
- 3 filings
- 3 insiders, $308.0K in total
- Insiders trading
- 4
- Net value
- −$283.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Corbus Pharmaceuticals Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ben Yong | Director | 9,383 | Sep 15, 2026 | 2 |
| Nicacio Leonardo Viana | Chief Medical Officer | 58,333 | Aug 17, 2026 | 1 |
| Saxena Nishant C | Chief Business Officer | 77,900 | Aug 12, 2026 | 3 |
| Cohen Yuval | Chief Executive Officer | 157,316 | Aug 10, 2026 | 4 |
| Moran Sean F. | Chief Financial Officer | 84,694 | Aug 10, 2026 | 4 |
| Kung Winston | Director | 12,140 | Jun 11, 2026 | 2 |
| Jenkins John Kenneth | Director | 3,833 | Jun 11, 2026 | 2 |
| Altmeyer Anne | Director | 7,579 | Jun 11, 2026 | 3 |
| Jacques Rachelle Suzanne | Director | 11,383 | May 21, 2026 | 1 |
| Pfeiffenberger Brent | Director | 7,500 | May 21, 2026 | 1 |
| Smethurst Dominic | Chief Medical Officer | 89,790 | Mar 4, 2026 | 3 |
| Hodgson Ian | Chief Operating Officer | 51,080 | Feb 18, 2026 | 3 |
| Cormorant Asset Management, LP | 10% Owner | 2,344,971Indirect | Dec 15, 2025 | 1 |
| Chen Bihua | 10% Owner | 2,344,971Indirect | Dec 15, 2025 | 1 |
| Cormorant Global Healthcare Master Fund, LP | 10% Owner | 2,344,971Indirect | Dec 15, 2025 | 1 |
| Holmer Alan F | Director | 10,629 | Jun 2, 2025 | 0 |
| Catlin Avery W | Director | 4,350 | Jun 3, 2024 | 0 |
| Salzmann Peter | Director | 2,783 | Jun 3, 2024 | 0 |
| Millian Craig Stuart | Chief Operating Officer | 27,000 | Feb 15, 2023 | 0 |
| Brake Rachael Louise | Chief Scientific Officer | – | Feb 15, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:59 PM ET | Sep 14 | 1 day | Ben YongDirector | SSaleCommon Stock, par value $0.0001 per share | −2.00K | $7.84 | −$15.7K | −17.6%9.38K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:30 PM ET | Aug 11 | 1 day | Saxena Nishant CChief Business Officer | PPurchaseCommon Stock, par value $0.0001 per share | +2.60K | $9.63 | +$25.0K | +3.5%77.9K after | |
| Aug 10, 2026 (view filing)4:30 PM ET | Aug 7 | 3 days | Cohen YuvalChief Executive Officer | SSaleCommon Stock, par value $0.0001 per share | −17.0K | $10.08 | −$171.4K | −9.8%157.3K after | 10b5-1 |
| Aug 10, 2026 (view filing)4:30 PM ET | Aug 7 | 3 days | Moran Sean F.Chief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −12.0K | $10.08 | −$121.0K | −12.4%84.7K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Kung WinstonDirector | SSaleCommon Stock, par value $0.0001 per share | −2.03K | $7.91 | −$16.0K | −14.3%12.1K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Jenkins John KennethDirector | SSaleCommon Stock, par value $0.0001 per share | −4.80K | $7.91 | −$38.0K | −55.6%3.83K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Altmeyer AnneDirector | SSaleCommon Stock, par value $0.0001 per share | −2.41K | $7.91 | −$19.1K | −24.1%7.58K after | 10b5-1 |
| Jun 3, 2026 (view filing) | Jun 2-3 | 1 day | Saxena Nishant CChief Business Officer | PPurchaseCommon Stock, par value $0.0001 per share | +13.5K | $7.50 | +$101.2K | +21.8%75.3K after | 2 lots |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Smethurst DominicChief Medical Officer | SSaleCommon Stock, par value $0.0001 per share | −6.10K | $8.30 | −$50.6K | −6.4%89.8K after | |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Hodgson IanChief Operating Officer | SSaleCommon Stock, par value $0.0001 per share | −847 | $7.38 | −$6.25K | −1.6%51.1K after | |
| Feb 18, 2026 (view filing) | Feb 13 | 5 days | Moran Sean F.Chief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −4.70K | $7.78 | −$36.6K | −4.6%96.7K after | 10b5-1 |
| Feb 18, 2026 (view filing) | Feb 13 | 5 days | Cohen YuvalChief Executive Officer | SSaleCommon Stock, par value $0.0001 per share | −13.9K | $7.78 | −$107.9K | −7.4%174.3K after | 10b5-1 |
| Feb 4, 2026 (view filing) | Feb 3 | 1 day | Smethurst DominicChief Medical Officer | SSaleCommon Stock, par value $0.0001 per share | −3.29K | $8.09 | −$26.6K | −3.3%95.9K after | |
| Feb 4, 2026 (view filing) | Feb 3 | 1 day | Hodgson IanChief Operating Officer | SSaleCommon Stock, par value $0.0001 per share | −2.42K | $8.09 | −$19.5K | −4.4%51.9K after | |
| Dec 15, 2025 (view filing)4:18 PM ET | Dec 11 | 4 days | Cormorant Asset Management, LP and 2 others10% Owner | SSale | −30.0K | $11.46 | −$344.0K | −1.3%2.34M after | |
| Oct 27, 2025 (view filing) | Oct 24-27 | 3 days | Cohen YuvalChief Executive Officer | SSaleCommon Stock, par value $0.0001 per share | −27.6K | $17.05 | −$471.2K | −16.7%138.2K after | 2 lots10b5-1 |
| Oct 27, 2025 (view filing) | Oct 24 | 3 days | Moran Sean F.Chief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −13.0K | $17.02 | −$220.9K | −15.0%73.3K after | 10b5-1 |
| Oct 21, 2025 (view filing) | Oct 20 | 1 day | Altmeyer AnneDirector | SSaleCommon Stock, par value $0.0001 per share | −1.06K | $20.50 | −$21.7K | −14.6%6.19K after | 10b5-1 |
| Jun 2, 2025 (view filing) | May 30 | 3 days | Jenkins John KennethDirector | SSaleCommon Stock, par value $0.0001 per share | −2.78K | $7.35 | −$20.5K | −98.8%33 after | 10b5-1 |
| Jun 2, 2025 (view filing) | May 30 | 3 days | Altmeyer AnneDirector | SSaleCommon Stock, par value $0.0001 per share | −1.39K | $7.25 | −$10.1K | −50.0%1.39K after | 10b5-1 |
| Mar 7, 2025 (view filing) | Mar 6 | 1 day | Smethurst DominicChief Medical Officer | SSaleCommon Stock, par value $0.0001 per share | −6.39K | $6.78 | −$43.3K | −8.3%70.8K after | |
| Feb 18, 2025 (view filing) | Feb 14 | 4 days | Moran Sean F.Chief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −2.79K | $8.76 | −$24.5K | −3.7%73.3K after | 10b5-1 |
| Feb 18, 2025 (view filing) | Feb 14 | 4 days | Cohen YuvalChief Executive Officer | SSaleCommon Stock, par value $0.0001 per share | −7.13K | $8.76 | −$62.5K | −4.9%138.2K after | 10b5-1 |
| Sep 24, 2024 (view filing)4:04 PM ET | Sep 20 | 4 days | Cormorant Asset Management, LP and 2 others10% Owner | PPurchase | +350.0K | $20.01 | +$7.00M | +17.3%2.38M after | 6 lots |
| Jun 18, 2024 (view filing) | Jun 14-18 | 4 days | Moran Sean F.Chief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −18.0K | $47.87 | −$863.8K | −27.1%48.6K after | 4 lots10b5-1 |
| Jun 18, 2024 (view filing) | Jun 14-18 | 4 days | Cohen YuvalChief Executive Officer | SSaleCommon Stock, par value $0.0001 per share | −63.4K | $46.57 | −$2.95M | −45.1%77.2K after | 8 lots10b5-1 |
| Mar 11, 2024 (view filing)5:34 PM ET | Mar 7-8 | 4 days | Cormorant Asset Management, LP and 2 others10% Owner | PPurchase | +550.0K | $42.41 | +$23.3M | +37.3%2.02M after | 10 lots |
| Feb 6, 2024 (view filing)4:00 PM ET | Feb 2 | 4 days | Cormorant Asset Management, LP and 2 others10% Owner | PPurchase | +750.0K | $19.00 | +$14.3M | +103.4%1.48M after | |
| Jan 30, 2024 (view filing)4:23 PM ET | Jan 26 | 4 days | Cormorant Asset Management, LP and 2 others10% Owner | PPurchase | +282.6K | $32.24 | +$9.11M | +63.9%725.0K after | 14 lots |
| Aug 12, 2022 (view filing)9:43 AM ET | Aug 10 | 2 days | Millian Craig StuartChief Operating Officer | PPurchase | +5.00K | $0.2545 | +$1.27K | +22.7%27.0K after | |
| Aug 11, 2022 (view filing)9:55 AM ET | Aug 10 | 1 day | Cohen YuvalChief Executive Officer | PPurchase | +3.80K | $0.264 | +$1.00K | +4.0%98.2K after | |
| Aug 10, 2022 (view filing)10:16 AM ET | Aug 10 | Same day | Moran Sean F.Chief Financial Officer | PPurchase | +20.0K | $0.2599 | +$5.20K | +11.2%199.3K after | |
| May 16, 2022 (view filing)11:03 AM ET | May 16 | Same day | Moran Sean F.Chief Financial Officer | PPurchase | +12.0K | $0.30 | +$3.60K | +7.2%179.3K after | |
| May 16, 2022 (view filing)10:41 AM ET | May 16 | Same day | Cohen YuvalChief Executive Officer | PPurchase | +10.5K | $0.25 | +$2.63K | +12.5%94.4K after | |
| Mar 11, 2022 (view filing)11:23 AM ET | Mar 10 | 1 day | Millian Craig StuartChief Operating Officer | PPurchase | +10.0K | $0.37 | +$3.70K | +83.3%22.0K after | |
| Mar 10, 2022 (view filing)11:47 AM ET | Mar 10 | Same day | Moran Sean F.Chief Financial Officer | PPurchase | +15.0K | $0.37 | +$5.55K | +9.9%167.3K after | |
| Mar 9, 2022 (view filing)10:37 AM ET | Mar 9 | Same day | Cohen YuvalChief Executive Officer | PPurchase | +8.60K | $0.37 | +$3.18K | +11.4%83.9K after |